ETON (Eton Corp) Multiplikator Forward P/S

Lambang korporat lan logo Eton Pharmaceuticals (ETON)

Eton Pharmaceuticals focuses on the commercialization of undervalued endocrine agents, while its primary revenue is generated from the sale of rare disease therapies through insurers. The projected P/S ratio helps assess the risks of inflated expectations, with 7.80 representing the latest level. Business stability is supported by operating cash flow from orphan drugs, which provides sufficient self-funding for new developments.

Eton Pharmaceuticals, Inc. - Multiplikator Forward P/S ETON (periode 04.07.2022 - 16.11.2026)

Ringkesan rincian data analitis Eton Pharmaceuticals (ETON)

Analisis fundamental perusahaan:etonpharma.com ETON
Produk asli Eton Corp

Forward P/S reflects the market value of a business relative to expected sales, allowing an investor to identify whether an asset is overbought or to determine a fair valuation range. By analyzing the projected P/S of the business, one can assess the extent to which the premium valuation of Eton Pharmaceuticals (ETON) is justified by its strong pricing power in the orphan drug niche and guaranteed reimbursement from insurers.

Analisis pesaing

Rasio rega marang prakiraan pendapatan Vertex VRTX|ALNY (Alnylam Inc.) - Rega mangsa ngarep marang pendapatan|Insmed Incorporated - Multiplikator Forward P/S|Rega forward marang dodolan UTHR (United Therapeutics)|BMRN: Multiplikator Forward P/S|BridgeBio Pharma (BBIO) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan bgm.ltd|COGT: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan xerispharma.com (XERS)|Multiplikator forward rega marang pendapatan Keros Therapeutics KROS|Multiplikator Forward P/S ARCT (arcturusrx.com)|Multiplikator Forward P/S Kamada Ltd KMDA|Fulcrum Therapeutics, Inc. - Multiplikator Forward P/S|ABEO - Multiplikator Forward P/S|MREO: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Protalix BioTherapeutics, Inc. (PLX)|PLRX (Pliant Therapeutics, Inc.) - Multiplikator Forward P/S|Applied Therapeutics Inc. - Rega mangsa ngarep marang pendapatan|Rasio rega marang prakiraan pendapatan Rein Therapeutics Inc (RNTX)|Rasio rega marang pendapatan sing dikarepake GELS|Aytu BioPharma, Inc. - Multiplikator forward rega marang pendapatan|Chemomab Therapeutics (CMMB) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|SRx Health - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Polyrizon Limited PLRZ|AEZS: Multiplikator Forward P/S|CYTH: Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan INZY|RPHM: Rega forward marang dodolan|Multiplikator forward rega marang pendapatan CSCI (COSCIENS Biopharma)